Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome-Reference-Cited by-同舟云学术

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome

Published:2014-04-21 Issue:4 Volume:9 Page:e95055
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Demyanets Svitlana,Speidl Walter S.,Tentzeris Ioannis,Jarai Rudolf,Katsaros Katharina M.,Farhan Serdar,Krychtiuk Konstantin A.,Wonnerth Anna,Weiss Thomas W.,Huber Kurt,Wojta Johann

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. T1/ST2–an IL-1 receptor-like modulator of immune responses;V Trajkovic;Cytokine Growth Factor Rev,2004

2. The IL-33/ST2 pathway: therapeutic target and novel biomarker;R Kakkar;Nat Rev Drug Discov,2008

3. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines;J Schmitz;Immunity,2005

4. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells;H Iwahana;Eur J Biochem,1999

5. IL-33 reduces the development of atherosclerosis;AM Miller;J Exp Med,2008

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Prognostic Potential of Plasma ST2 in Patients with Peripheral Artery Disease: Identification and Evaluation;Proteomes;2024-08-29

2. Soluble ST2 is associated with postoperative atrial fibrillation after cardiac surgery in postmenopausal women;Clinica Chimica Acta;2024-07

3. Musculoskeletal disorders and coronary artery disease —promising molecular markers: literature review;CardioSomatics;2024-04-10

4. Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA study;Cardiovascular Diabetology;2024-02-03

5. Roles of IL-33 in the Pathogenesis of Cardiac Disorders;Experimental Biology and Medicine;2023-10-12